Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023)

Talphera's (TLPH) quarterly Long-Term Debt Repayments came in at $3.3 million in Q2 2023, up 60.01% year-on-year from $2.1 million in Q2 2022, and up 60.01% quarter-over-quarter from $2.1 million in Q1 2023.

Talphera (TLPH) Long-Term Debt Repayments (2010 - 2023) Analysis & Trends

Talphera's Long-Term Debt Repayments history runs 10 years deep, the most recent figure standing at $3.3 million for Q2 2023.

  • On a quarterly basis, Long-Term Debt Repayments rose 60.01% year-over-year to $3.3 million in Q2 2023; TTM through Mar 2024 was $3.3 million, a 60.48% decrease from a year earlier, with the FY2023 full-year figure at $5.4 million, down 35.78% from the prior year.
  • Long-Term Debt Repayments advanced to $3.3 million in Q2 2023 per TLPH's latest filing, from $2.1 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $3.3 million in Q2 2023 and bottomed at $1.4 million in Q2 2019.
  • The 5-year median for Long-Term Debt Repayments is $2.1 million (2020), against an average of $2.2 million.
  • Across the five-year window, Long-Term Debt Repayments retreated 25.96% in 2019 and jumped 60.01% in 2023, its largest moves.
  • Year by year, Long-Term Debt Repayments stood at $1.4 million in 2019, then jumped by 48.22% to $2.1 million in 2020, then fell by 0.05% to $2.1 million in 2021, then gained by 4.8% to $2.2 million in 2022, then soared by 52.68% to $3.3 million in 2023.
  • Per Business Quant, the three latest TLPH Long-Term Debt Repayments figures stand at $3.3 million (Q2 2023), $2.1 million (Q1 2023), and $2.2 million (Q4 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 23.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -478.39 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Talphera 47.31 Mn 9.48 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 3.33 Mn
Jun 30, 2023 3.33 Mn
Mar 31, 2023 2.08 Mn
Mar 31, 2023 2.08 Mn
Dec 31, 2022 2.18 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 2.08 Mn
Sep 30, 2022 2.08 Mn
Jun 30, 2022 2.08 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 2.08 Mn
Mar 31, 2022 2.08 Mn
Dec 31, 2021 2.08 Mn
Dec 31, 2021 2.08 Mn
Sep 30, 2021 2.58 Mn
Sep 30, 2021 2.58 Mn
Jun 30, 2021 2.08 Mn
Jun 30, 2021 2.08 Mn
Mar 31, 2021 2.08 Mn
Mar 31, 2021 2.08 Mn